Trace Neuroscience
PrivateLast Round
Series A
Nov 12, 2024
Total Funding Raised
$101M
Company Overview
Trace Neuroscience is a biopharmaceutical company developing novel genomic therapies to restore UNC13A protein function for the treatment of amyotrophic lateral sclerosis (ALS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trace Neuroscience Comparables
Compare Trace Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harness Therapeutics | 86% | |
| AcuraStem | 86% | |
| NuCyRNA Therapeutics | 86% | |
Trace Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 12, 2024 |
Key People
Founding team and executive leadership
Trace Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| GV | Series A |
| Atlas Venture | Series A |
| Third Rock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 25, 2026
Developing medicines to restore UNC13A gene function for nerve-muscle communication.
- Nov 12, 2024
$101M round led by Third Rock Ventures
Trace Neuroscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Trace Neuroscience's valuation, stock price, and market status.